Australia - English - Department of Health (Therapeutic Goods Administration)

ambu australia pty ltd - 65299 - flexible video gastroscope, single-use - the ascope gastro is a sterile, single use flexible gastroscope intended to be used for endoscopic access to and examination of the upper gastrointestinal anatomy. it provides visualisation via a compatable ambu display unit and to be used with endo-therapy accessories and other ancillary equipment.

Australia - English - Department of Health (Therapeutic Goods Administration)

ambu australia pty ltd - 66115 - bronchoscopic specimen collection container - the ambu ascope bronchsampler is an accessory to the ascope broncho. it is a closed loop system, when connected to the ascope broncho that allows the collection of bronchial samples reducing the chance of contamination and loss.

Australia - English - Department of Health (Therapeutic Goods Administration)

ambu australia pty ltd - 18034 - endoscopic video image processor - the aview 2 advance monitor can be connected to multiple ambu single-use visualisation devices (e.g. bronchoscope, cystoscope, rhino-laryngoscope, double-lumen et tube with camera) to allow the visualisation of a condition or disease state relating to the patient anatomy associated with the specific visualisation device being used. the visualised image informs & supports the surgeon/clinician when making clinical decisions?

Australia - English - Department of Health (Therapeutic Goods Administration)

ambu australia pty ltd - 45036 - airway, laryngeal, single-use - the ambu laryngeal mask is intended for use as an alternative to a facemask for achieving and maintaining control of the airway during routine and emergency anaesthetic procedures in fasted patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

ambu australia pty ltd - 11441 - electrode, electromyograph - electromyography (emg) needle electrode designed for botulinum toxin therapy during nerve block procedures. the ambu neuroline inoject needle electrode is indicated for emg guided injection of botulinum toxin for nerve block procedures. intended patient population: ? children: 2 years to less than 12 years ? adolescents: aged 12 through 21 (up to but not including the 22nd birthday) ? adults: age 22 and up

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - entecavir monohydrate, quantity: 0.532 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; macrogol 6000 - entac is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation.,this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - entecavir monohydrate, quantity: 1.064 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hyprolose; crospovidone; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - entac is indicated for the treatment of chronic hepatitis b virus infection in adults 16 years or older with evidence of active liver inflammation.,this indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with hbeag-positive or hbeag-negative chronic hbv infection with compensated liver disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sodium hydroxide; water for injections; lactic acid; sorbitol - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sorbitol; lactic acid; water for injections; sodium hydroxide - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; purified talc; magnesium stearate; pregelatinised maize starch; sodium lauryl sulfate; colloidal anhydrous silica; hyprolose; stearic acid - for the temporary relief of acute moderate pain